FCF Yield
Higher than 98% of Healthcare sector peers
Updated 1078h ago
Sector Performance
98th percentileKROS
14.0%
Sector Median
3.6%
Sector Avg
-6.8%
Deep Analysis
Keros Therapeutics, Inc. (KROS) has a FCF Yield of 14.0% as of May 2026.
This places KROS in the 98th percentile of the Healthcare sector, which has a median FCF Yield of 3.6% and a sector average of -6.8%. KROS's FCF Yield is 288.9% above the sector median, a significant divergence that warrants closer examination. In context: One of the purest measures of value. High FCF yield means the company generates a lot of cash relative to its price — favoured by value investors.
Frequently Asked Questions
What does the FCF Yield tell investors about KROS?
One of the purest measures of value. High FCF yield means the company generates a lot of cash relative to its price — favoured by value investors.
How is the FCF Yield calculated?
FCF Yield is calculated as: Free Cash Flow / Market Cap.
How does KROS's FCF Yield compare to its sector?
KROS's FCF Yield of 14.0% compares to a Healthcare sector median of 3.6%, placing it in the 98th percentile.
Who are KROS's closest peers by FCF Yield?
The closest Healthcare peers by FCF Yield include: AZN (3.2%), BAX (3.1%), INSP (2.9%), TECH (2.9%), A (2.8%).
The Formula
Free Cash Flow / Market Cap
Why It Matters
One of the purest measures of value. High FCF yield means the company generates a lot of cash relative to its price — favoured by value investors.
Master KROS's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full KROS research report →KROS
14.0%
Sector Median
3.6%
Sector Avg
-6.8%
How KROS's FCF Yield compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.